AAAAAA
Results: 26-41/41
Authors:
Lee, BN
Duvic, M
Tang, CK
Bueso-Ramos, C
Estrov, Z
Reuben, JM
Citation: Bn. Lee et al., Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma, CL DIAG LAB, 6(1), 1999, pp. 79-84
Authors:
Estrov, Z
Freedman, MH
Citation: Z. Estrov et Mh. Freedman, Detection of residual disease in acute lymphoblastic leukemia of childhood, LEUK LYMPH, 33(1-2), 1999, pp. 47-52
Authors:
Andreeff, M
Jiang, S
Zhang, X
Konopleva, M
Estrov, Z
Snell, VE
Xie, Z
Okcu, MF
Sanchez-Williams, G
Dong, J
Estey, EH
Champlin, RC
Kornblau, SM
Reed, JC
Zhao, S
Citation: M. Andreeff et al., Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid, LEUKEMIA, 13(11), 1999, pp. 1881-1892
Authors:
Mavligit, GM
Estrov, Z
Ayala, A
Citation: Gm. Mavligit et al., Carcinoma of the stomach metastatic to the liver that progressed after hepatic arterial infusion of cisplatin plus 5-floxuridine, and then dramatically regressed after chemoembolization based on positive chromogranin staining, AM J CL ONC, 22(3), 1999, pp. 320-322
Authors:
Albitar, M
Manshouri, T
Kantarjian, H
Keating, M
Estrov, Z
Faber, J
Freireich, EJ
Pierce, S
Estey, E
Citation: M. Albitar et al., Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia, LEUK RES, 23(1), 1999, pp. 63-69
Authors:
Faderl, S
Talpaz, M
Estrov, Z
O'Brien, S
Kurzrock, R
Kantarjian, HM
Citation: S. Faderl et al., Mechanisms of disease - The biology of chronic myeloid leukemia, N ENG J MED, 341(3), 1999, pp. 164-172
Authors:
Faderl, S
Estrov, Z
Citation: S. Faderl et Z. Estrov, Detection of residual disease in childhood acute lymphoblastic leukemia, N ENG J MED, 340(2), 1999, pp. 152-153
Authors:
Beaupre, DM
Talpaz, M
Marini, FC
Cristiano, RJ
Roth, JA
Estrov, Z
Albitar, M
Freedman, MH
Kurzrock, R
Citation: Dm. Beaupre et al., Autocrine interleukin-1 beta production in leukemia: Evidence for the involvement of mutated RAS, CANCER RES, 59(12), 1999, pp. 2971-2980
Authors:
Estrov, Z
Manna, SK
Harris, D
Van, Q
Estey, EH
Kantarjian, HM
Talpaz, M
Aggarwal, BB
Citation: Z. Estrov et al., Phenylarsine oxide blocks interleukin-1 beta-induced activation of the nuclear transcription factor NF-kappa B, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells, BLOOD, 94(8), 1999, pp. 2844-2853
Authors:
Faderl, S
Talpaz, M
Kantarjian, HM
Estrov, Z
Citation: S. Faderl et al., Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction and clinical decision making - Response, BLOOD, 94(4), 1999, pp. 1487-1488
Authors:
Aguayo, A
Estey, E
Kantarjian, H
Mansouri, T
Gidel, C
Keating, M
Giles, F
Estrov, Z
Barlogie, B
Albitar, M
Citation: A. Aguayo et al., Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia, BLOOD, 94(11), 1999, pp. 3717-3721
Authors:
Faderl, S
Talpaz, M
Kantarjian, HM
Estrov, Z
Citation: S. Faderl et al., Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia - Response, BLOOD, 94(10), 1999, pp. 3610-3611
Authors:
Faderl, S
Talpaz, M
Kantarjian, HM
Estrov, Z
Citation: S. Faderl et al., Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?, BLOOD, 93(9), 1999, pp. 2755-2759
Authors:
Konopleva, M
Mikhail, A
Estrov, Z
Zhao, SR
Harris, D
Sanchez-Williams, G
Kornblau, SM
Dong, J
Kliche, KO
Jiang, SW
Snodgrass, HR
Estey, EH
Andreeff, M
Citation: M. Konopleva et al., Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: Proliferative and anti-apoptotic activities, BLOOD, 93(5), 1999, pp. 1668-1676
Authors:
Faderl, S
Kurzrock, R
Estrov, Z
Citation: S. Faderl et al., Minimal residual disease in hematologic disorders, ARCH PATH L, 123(11), 1999, pp. 1030-1034
Authors:
Faderl, S
Talpaz, M
Estrov, Z
Kantarjian, HM
Citation: S. Faderl et al., Chronic myelogenous leukemia: Biology and therapy, ANN INT MED, 131(3), 1999, pp. 207-219